INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
793,851
Share change
+56,399
Total reported value
$19,870,000
Price per share
$25.04
Number of holders
26
Value change
+$1,408,760
Number of buys
11
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q4 2021

As of 31 Dec 2021, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 793,851 shares. The largest 10 holders included JANE STREET GROUP, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, V Wealth Advisors LLC, AE Wealth Management LLC, ENVESTNET ASSET MANAGEMENT INC, GeoWealth Management, LLC, and TAP Consulting, LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.